CLINICAL_TRIALS
trial_result
· 2020-10-19
Clinical Trial Update: Study of an Experimental New Drug, PPARγ Agonist Taken by Mouth by Participants With Advanced or Metastatic Cancer [Phase 1]
Summary
Phase 1 trial of an oral PPARγ agonist in advanced or metastatic cancer completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Daiichi Sankyo | Conditions: Neoplasm | Phase 1 | Status: COMPLETED | Results posted: 2020-10-19